Tag: Dana-Farber/Boston Children’s Cancer and Blood Disorders
-
Nation & World
Making cancer vulnerable to immune attack
CRISPR-Cas9 genome editing technology revealed a promising new class of cancer immunotherapy.
-
Sections
Featured Topics
Featured series Wondering
A series of random questions answered by Harvard experts.
Explore the Gazette
Read the latest